Cargando…
Potential Adverse Effects of Dexamethasone Therapy on COVID-19 Patients: Review and Recommendations
In the context of the coronavirus disease 2019 (COVID-19) pandemic, the global healthcare community has raced to find effective therapeutic agents against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To date, dexamethasone is the first and an important therapeutic to significantly r...
Autores principales: | Chen, Fei, Hao, Lanting, Zhu, Shiheng, Yang, Xinyuan, Shi, Wenhao, Zheng, Kai, Wang, Tenger, Chen, Huiran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298044/ https://www.ncbi.nlm.nih.gov/pubmed/34296386 http://dx.doi.org/10.1007/s40121-021-00500-z |
Ejemplares similares
-
Dexamethasone and lactoferrin induced PMN-MDSCs relieved inflammatory adverse events of anti-cancer therapy without tumor promotion
por: Li, Xing, et al.
Publicado: (2021) -
Reducing dexamethasone antiemetic prophylaxis during the COVID-19 pandemic: recommendations from Ontario, Canada
por: Grant, Robert C., et al.
Publicado: (2020) -
FGF23 protects osteoblasts from dexamethasone-induced oxidative injury
por: Ji, Feng, et al.
Publicado: (2020) -
Dexamethasone prevents TACE-induced adverse events: A meta-analysis
por: Chang, Lei, et al.
Publicado: (2020) -
Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel()()
por: Cury-Martins, Jade, et al.
Publicado: (2020)